Subnetwork | Dataset | Score | p-value 1 | p-value 2 | p-value 3 | Size | Highlighted genes |
---|---|---|---|---|---|---|---|
int-snw-10296 | tai-screen-luciferase | 6.413 | 3.70e-138 | 2.79e-07 | 2.32e-03 | 18 | 15 |
reg-snw-84343 | tai-screen-luciferase | 4.236 | 2.24e-19 | 3.52e-03 | 4.83e-03 | 10 | 5 |
int-snw-4831 | tai-screen-luciferase | 6.314 | 3.38e-133 | 5.36e-07 | 3.08e-03 | 24 | 20 |
int-snw-51382 | tai-screen-luciferase | 7.286 | 3.65e-186 | 4.21e-10 | 1.27e-04 | 13 | 12 |
int-snw-51741 | tai-screen-luciferase | 6.174 | 2.67e-126 | 1.32e-06 | 4.54e-03 | 24 | 19 |
int-snw-7133 | tai-screen-luciferase | 6.428 | 5.80e-139 | 2.51e-07 | 2.21e-03 | 25 | 20 |
int-snw-6189 | tai-screen-luciferase | 7.011 | 2.96e-170 | 3.75e-09 | 3.42e-04 | 18 | 16 |
int-snw-7372 | tai-screen-luciferase | 6.242 | 1.24e-129 | 8.55e-07 | 3.77e-03 | 23 | 19 |
Gene Symbol | Entrez Gene ID | Frequency | tai-screen-luciferase gene score | Best subnetwork score | Degree | List-Gonzales GI | Tai-Hits |
---|---|---|---|---|---|---|---|
RPS20 | 6224 | 22 | -4.757 | 6.314 | 153 | Yes | - |
RPS8 | 6202 | 33 | -5.545 | 7.555 | 234 | - | - |
MAPK8 | 5599 | 28 | -4.403 | 6.468 | 153 | - | - |
CHMP2A | 27243 | 33 | -9.037 | 7.555 | 41 | Yes | Yes |
RPS15 | 6209 | 30 | -5.040 | 7.011 | 116 | Yes | - |
COPA | 1314 | 48 | -9.395 | 5.672 | 340 | Yes | Yes |
RNF20 | 56254 | 28 | -4.564 | 6.174 | 18 | - | - |
CTSF | 8722 | 8 | -3.978 | 4.236 | 1 | - | Yes |
RPS29 | 6235 | 17 | -8.386 | 6.597 | 29 | - | - |
HSF1 | 3297 | 46 | -4.179 | 5.027 | 209 | - | Yes |
PLA2G12A | 81579 | 10 | 2.326 | 6.242 | 9 | - | - |
SRC | 6714 | 28 | -2.806 | 6.174 | 419 | Yes | - |
COPB2 | 9276 | 48 | -13.168 | 9.063 | 41 | Yes | Yes |
CKAP5 | 9793 | 46 | -7.214 | 5.672 | 130 | Yes | Yes |
ATG4C | 84938 | 10 | 2.130 | 6.242 | 321 | - | - |
EIF2S2 | 8894 | 31 | -4.320 | 5.672 | 103 | Yes | - |
RPS16 | 6217 | 38 | -5.444 | 4.880 | 205 | - | - |
CDC42 | 998 | 44 | -6.960 | 4.707 | 276 | Yes | Yes |
UTP18 | 51096 | 8 | -1.709 | 4.236 | 106 | - | - |
MAEA | 10296 | 13 | -2.793 | 6.413 | 43 | - | - |
RPS11 | 6205 | 44 | -6.588 | 7.555 | 175 | Yes | - |
ARL1 | 400 | 18 | -4.142 | 8.046 | 110 | - | Yes |
NME2 | 4831 | 24 | -3.034 | 4.325 | 53 | - | - |
RPS6 | 6194 | 44 | -5.603 | 8.046 | 217 | Yes | - |
TLK2 | 11011 | 21 | -4.011 | 5.672 | 14 | - | - |
RAN | 5901 | 38 | -3.809 | 4.325 | 258 | Yes | Yes |
UBB | 7314 | 30 | -4.289 | 6.428 | 147 | - | - |
RPS18 | 6222 | 10 | -3.709 | 6.428 | 169 | Yes | - |
COPB1 | 1315 | 39 | -6.221 | 9.063 | 118 | Yes | Yes |
SERBP1 | 26135 | 35 | -4.612 | 5.516 | 106 | - | Yes |
RPS23 | 6228 | 21 | -4.485 | 6.375 | 118 | Yes | - |
RPS13 | 6207 | 43 | -6.589 | 7.555 | 174 | Yes | - |
CDC5L | 988 | 34 | -3.419 | 5.672 | 155 | - | - |
HPS3 | 84343 | 8 | -1.516 | 4.236 | 41 | - | - |
RPS24 | 6229 | 46 | -7.034 | 8.389 | 217 | Yes | - |
TUBA1C | 84790 | 10 | -4.660 | 6.242 | 91 | - | Yes |
VIM | 7431 | 18 | -3.760 | 6.428 | 246 | - | - |
TCERG1 | 10915 | 28 | -3.808 | 6.174 | 58 | Yes | - |
RPS9 | 6203 | 45 | -7.127 | 7.555 | 140 | Yes | - |
RPS3A | 6189 | 19 | -4.647 | 7.189 | 166 | Yes | - |
TNFRSF1B | 7133 | 10 | -3.319 | 6.428 | 109 | - | - |
RPS4X | 6191 | 44 | -6.747 | 7.555 | 263 | Yes | - |
COPZ1 | 22818 | 48 | -8.301 | 9.063 | 13 | Yes | Yes |
ATP6V1D | 51382 | 30 | -4.131 | 7.286 | 149 | - | - |
BRCA2 | 675 | 8 | -1.991 | 4.236 | 111 | - | - |
RPS15A | 6210 | 36 | -5.413 | 7.555 | 177 | Yes | - |
WWOX | 51741 | 28 | -2.448 | 6.174 | 38 | - | - |
RPS27A | 6233 | 45 | -5.631 | 8.389 | 344 | Yes | - |
RPS14 | 6208 | 23 | -4.803 | 7.011 | 204 | Yes | - |
RPS19 | 6223 | 21 | -4.701 | 4.752 | 102 | Yes | - |
SKP1 | 6500 | 26 | -3.750 | 6.413 | 203 | - | - |
UMPS | 7372 | 10 | 1.909 | 6.242 | 18 | - | - |
NFKBIB | 4793 | 28 | -3.978 | 6.174 | 78 | - | - |
RPS26 | 6231 | 43 | -7.478 | 8.046 | 60 | Yes | - |
ARCN1 | 372 | 48 | -8.232 | 9.063 | 118 | Yes | Yes |
COPG1 | 22820 | 12 | -5.279 | 7.138 | 37 | Yes | Yes |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
CDC42 | 998 | RPS27A | 6233 | pp | -- | int.I2D: SOURAV_MAPK_HIGH |
RPS20 | 6224 | RPS26 | 6231 | pp | -- | int.I2D: YeastLow |
RPS4X | 6191 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
RPS27A | 6233 | SKP1 | 6500 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
NME2 | 4831 | RPS19 | 6223 | pp | -- | int.Proteinpedia: Mass spectrometry |
TUBA1C | 84790 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
ARCN1 | 372 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, Tarassov_PCA, YeastMedium, INTEROLOG |
RPS3A | 6189 | RPS18 | 6222 | pp | -- | int.I2D: YeastLow |
COPZ1 | 22818 | COPG1 | 22820 | pp | -- | int.I2D: BioGrid, HPRD, BIND; int.HPRD: in vitro, in vivo, yeast 2-hybrid; int.DIP: MI:0915(physical association) |
VIM | 7431 | SERBP1 | 26135 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, HPRD, BioGrid, MINT, StelzlHigh; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
RPS11 | 6205 | RPS15 | 6209 | pp | -- | int.I2D: INTEROLOG, YeastMedium |
RPS11 | 6205 | RPS19 | 6223 | pp | -- | int.I2D: IntAct_Yeast |
RPS18 | 6222 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS11 | 6205 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast |
TCERG1 | 10915 | WWOX | 51741 | pp | -- | int.I2D: BioGrid, MINT, Pawson1; int.Mint: MI:0915(physical association) |
RPS3A | 6189 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
EIF2S2 | 8894 | ATP6V1D | 51382 | pp | -- | int.I2D: YeastLow |
RPS14 | 6208 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS11 | 6205 | RPS18 | 6222 | pp | -- | int.I2D: YeastMedium, BioGrid_Yeast |
RPS13 | 6207 | RPS20 | 6224 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
RPS23 | 6228 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS11 | 6205 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
CDC5L | 988 | HPS3 | 84343 | pd | > | reg.ITFP.txt: no annot |
RPS14 | 6208 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
SRC | 6714 | CKAP5 | 9793 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
RPS15 | 6209 | PLA2G12A | 81579 | pp | -- | int.Intact: MI:0915(physical association) |
RPS6 | 6194 | RPS26 | 6231 | pp | -- | int.I2D: YeastLow |
COPB2 | 9276 | COPG1 | 22820 | pp | -- | int.I2D: BioGrid |
ARCN1 | 372 | RAN | 5901 | pp | -- | int.I2D: YeastLow |
RPS15 | 6209 | RPS23 | 6228 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
RPS14 | 6208 | RPS20 | 6224 | pp | -- | int.I2D: INTEROLOG, YeastMedium, BioGrid_Yeast |
CDC42 | 998 | UBB | 7314 | pp | -- | int.I2D: SOURAV_MAPK_HIGH |
NFKBIB | 4793 | UBB | 7314 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
RPS15 | 6209 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS9 | 6203 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
RPS14 | 6208 | RPS15 | 6209 | pp | -- | int.I2D: INTEROLOG, YeastMedium |
RPS8 | 6202 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
RPS4X | 6191 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
RPS9 | 6203 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
RPS20 | 6224 | RPS23 | 6228 | pp | -- | int.I2D: YeastMedium, INTEROLOG |
NME2 | 4831 | RPS16 | 6217 | pp | -- | int.Proteinpedia: Mass spectrometry |
RPS8 | 6202 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS16 | 6217 | RPS20 | 6224 | pp | -- | int.I2D: BioGrid_Yeast |
RPS9 | 6203 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
SKP1 | 6500 | ATP6V1D | 51382 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
RPS13 | 6207 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
RPS15 | 6209 | RPS20 | 6224 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
TNFRSF1B | 7133 | UBB | 7314 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
RPS11 | 6205 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | RPS23 | 6228 | pp | -- | int.I2D: YeastLow, BioGrid_Yeast |
ARCN1 | 372 | COPG1 | 22820 | pp | -- | int.I2D: HPRD; int.HPRD: in vivo |
UTP18 | 51096 | HPS3 | 84343 | pd | > | reg.ITFP.txt: no annot |
RAN | 5901 | RPS11 | 6205 | pp | -- | int.I2D: IntAct_Worm, BioGrid_Worm, BIND_Worm, MINT_Worm, NON_CORE |
RPS6 | 6194 | RPS15 | 6209 | pp | -- | int.I2D: BioGrid_Yeast |
RPS14 | 6208 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast |
RPS3A | 6189 | RPS23 | 6228 | pp | -- | int.I2D: BioGrid_Yeast |
RPS18 | 6222 | RPS20 | 6224 | pp | -- | int.I2D: YeastMedium, INTEROLOG, YeastHigh |
RPS3A | 6189 | RPS9 | 6203 | pp | -- | int.I2D: IntAct |
RPS9 | 6203 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS14 | 6208 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS14 | 6208 | RPS18 | 6222 | pp | -- | int.I2D: BioGrid_Yeast |
RPS4X | 6191 | RPS9 | 6203 | pp | -- | int.I2D: BioGrid_Yeast |
RPS8 | 6202 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
RPS15A | 6210 | RPS18 | 6222 | pp | -- | int.I2D: YeastLow |
UBB | 7314 | WWOX | 51741 | pp | -- | int.I2D: BCI, HPRD; int.HPRD: in vivo |
RPS29 | 6235 | UMPS | 7372 | pp | -- | int.Intact: MI:0915(physical association) |
RPS27A | 6233 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
UBB | 7314 | RNF20 | 56254 | pp | -- | int.Intact: MI:0220(ubiquitination reaction); int.I2D: IntAct |
RPS8 | 6202 | SKP1 | 6500 | pp | -- | int.I2D: BioGrid_Yeast |
COPB1 | 1315 | COPG1 | 22820 | pp | -- | int.I2D: BioGrid, HPRD; int.HPRD: in vitro, in vivo, yeast 2-hybrid; int.DIP: MI:0915(physical association) |
RPS15A | 6210 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
RPS11 | 6205 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS11 | 6205 | ATP6V1D | 51382 | pp | -- | int.I2D: BioGrid_Yeast |
RPS3A | 6189 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS18 | 6222 | RPS23 | 6228 | pp | -- | int.I2D: YeastLow |
UMPS | 7372 | PLA2G12A | 81579 | pp | -- | int.Intact: MI:0915(physical association) |
RPS15 | 6209 | RPS18 | 6222 | pp | -- | int.I2D: INTEROLOG, YeastMedium, Yu_GoldStd |
RPS8 | 6202 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
SRC | 6714 | WWOX | 51741 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
RPS16 | 6217 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS15A | 6210 | RPS20 | 6224 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastHigh, YeastMedium |
MAEA | 10296 | ATP6V1D | 51382 | pp | -- | int.I2D: BioGrid_Yeast |
ARL1 | 400 | ATP6V1D | 51382 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | RPS18 | 6222 | pp | -- | int.I2D: YeastLow |
RPS13 | 6207 | RPS19 | 6223 | pp | -- | int.I2D: IntAct_Yeast |
RPS20 | 6224 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
RPS9 | 6203 | RPS18 | 6222 | pp | -- | int.I2D: IntAct |
RPS4X | 6191 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
RPS20 | 6224 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS27A | 6233 | UBB | 7314 | pp | -- | int.I2D: BIND |
RPS4X | 6191 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
ARL1 | 400 | COPA | 1314 | pp | -- | int.I2D: BioGrid_Yeast |
NME2 | 4831 | VIM | 7431 | pp | -- | int.HPRD: in vivo |
RAN | 5901 | RPS15 | 6209 | pp | -- | int.I2D: YeastLow |
UMPS | 7372 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS4X | 6191 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium, INTEROLOG |
RPS8 | 6202 | RPS9 | 6203 | pp | -- | int.I2D: BioGrid_Yeast |
TNFRSF1B | 7133 | VIM | 7431 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT; int.Mint: MI:0915(physical association) |
RPS3A | 6189 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
RPS8 | 6202 | RPS19 | 6223 | pp | -- | int.I2D: MINT |
RPS6 | 6194 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
RPS13 | 6207 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
RPS8 | 6202 | RPS20 | 6224 | pp | -- | int.I2D: BioGrid_Yeast |
RPS3A | 6189 | RPS4X | 6191 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | ATP6V1D | 51382 | pp | -- | int.I2D: BioGrid_Yeast |
COPA | 1314 | COPB1 | 1315 | pp | -- | int.I2D: BioGrid, BioGrid_Yeast, BIND_Yeast, IntAct_Yeast, MINT_Yeast, Krogan_Core, YeastHigh |
RPS8 | 6202 | CHMP2A | 27243 | pp | -- | int.I2D: BioGrid_Yeast |
RPS24 | 6229 | ATP6V1D | 51382 | pp | -- | int.I2D: BioGrid_Yeast |
CDC5L | 988 | CKAP5 | 9793 | pd | <> | reg.ITFP.txt: no annot |
RPS13 | 6207 | RPS18 | 6222 | pp | -- | int.I2D: BioGrid_Yeast |
RPS3A | 6189 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | PLA2G12A | 81579 | pp | -- | int.Intact: MI:0915(physical association) |
RPS3A | 6189 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
RPS23 | 6228 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
BRCA2 | 675 | CTSF | 8722 | pd | > | reg.ITFP.txt: no annot |
RPS14 | 6208 | UTP18 | 51096 | pd | < | reg.ITFP.txt: no annot |
HSF1 | 3297 | MAPK8 | 5599 | pp | -- | int.I2D: HPRD, INNATEDB; int.HPRD: in vitro, in vivo |
RPS3A | 6189 | RPS8 | 6202 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
COPA | 1314 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastMedium |
NFKBIB | 4793 | SKP1 | 6500 | pp | -- | int.I2D: HPRD, BCI; int.HPRD: in vitro |
RPS6 | 6194 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
RPS3A | 6189 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast |
COPA | 1314 | COPB2 | 9276 | pp | -- | int.I2D: BioGrid, HPRD, BCI; int.HPRD: in vivo |
COPB1 | 1315 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, Tarassov_PCA, YeastMedium; int.DIP: MI:0915(physical association) |
RPS18 | 6222 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS4X | 6191 | RPS18 | 6222 | pp | -- | int.I2D: BioGrid_Yeast |
COPA | 1314 | ATP6V1D | 51382 | pp | -- | int.I2D: YeastLow |
RPS15 | 6209 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
RPS3A | 6189 | RPS15 | 6209 | pp | -- | int.I2D: BioGrid_Yeast |
RPS4X | 6191 | RPS8 | 6202 | pp | -- | int.I2D: BioGrid_Yeast |
RPS14 | 6208 | TNFRSF1B | 7133 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: MINT, IntAct; int.Mint: MI:0915(physical association) |
SKP1 | 6500 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS4X | 6191 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
RPS15A | 6210 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
CDC5L | 988 | TLK2 | 11011 | pd | > | reg.ITFP.txt: no annot |
RPS18 | 6222 | TNFRSF1B | 7133 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: MINT, IntAct; int.Mint: MI:0915(physical association) |
RPS13 | 6207 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast |
ARCN1 | 372 | ARL1 | 400 | pp | -- | int.I2D: BioGrid_Yeast |
ARL1 | 400 | RPS6 | 6194 | pp | -- | int.I2D: BioGrid_Yeast |
RPS13 | 6207 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
RPS4X | 6191 | RPS15 | 6209 | pp | -- | int.I2D: INTEROLOG, YeastMedium |
RPS11 | 6205 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
CDC5L | 988 | COPA | 1314 | pd | <> | reg.ITFP.txt: no annot |
RPS24 | 6229 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
CDC5L | 988 | EIF2S2 | 8894 | pd | > | reg.ITFP.txt: no annot |
COPB1 | 1315 | COPB2 | 9276 | pp | -- | int.I2D: BioGrid |
ARCN1 | 372 | COPB1 | 1315 | pp | -- | int.I2D: BCI, BioGrid, BioGrid_Yeast, IntAct_Yeast, INTEROLOG, MINT_Yeast, YeastHigh, BIND, BIND_Yeast, HPRD, Krogan_Core, MIPS; int.HPRD: in vivo |
BRCA2 | 675 | HPS3 | 84343 | pd | > | reg.ITFP.txt: no annot |
RPS9 | 6203 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
RPS15 | 6209 | RPS15A | 6210 | pp | -- | int.I2D: YeastMedium, INTEROLOG |
RPS16 | 6217 | TNFRSF1B | 7133 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: MINT, IntAct; int.Mint: MI:0915(physical association) |
RPS6 | 6194 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
ARCN1 | 372 | RPS3A | 6189 | pp | -- | int.I2D: IntAct_Yeast |
RPS16 | 6217 | RPS23 | 6228 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | RPS20 | 6224 | pp | -- | int.I2D: YeastLow |
ARCN1 | 372 | COPA | 1314 | pp | -- | int.I2D: BCI, BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, YeastHigh, HPRD, Krogan_Core; int.HPRD: in vivo |
RPS6 | 6194 | RPS8 | 6202 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
RPS4X | 6191 | RPS6 | 6194 | pp | -- | int.I2D: BioGrid_Yeast |
RPS18 | 6222 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
CDC5L | 988 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid |
COPA | 1314 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
MAPK8 | 5599 | WWOX | 51741 | pp | -- | int.I2D: MINT, HPRD; int.Mint: MI:0915(physical association); int.HPRD: in vivo, yeast 2-hybrid |
RPS8 | 6202 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast |
COPB1 | 1315 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
COPA | 1314 | HPS3 | 84343 | pd | > | reg.ITFP.txt: no annot |
RPS16 | 6217 | RPS26 | 6231 | pp | -- | int.I2D: BioGrid_Yeast |
RAN | 5901 | ATP6V1D | 51382 | pp | -- | int.I2D: YeastLow |
COPB1 | 1315 | TNFRSF1B | 7133 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: MINT, IntAct; int.Mint: MI:0915(physical association) |
RPS15A | 6210 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
ARCN1 | 372 | COPB2 | 9276 | pp | -- | int.I2D: HPRD, BCI; int.HPRD: in vivo |
RAN | 5901 | SKP1 | 6500 | pp | -- | int.I2D: BioGrid_Yeast |
RPS4X | 6191 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
VIM | 7431 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS11 | 6205 | RPS20 | 6224 | pp | -- | int.I2D: YeastMedium, INTEROLOG |
RPS13 | 6207 | RPS15 | 6209 | pp | -- | int.I2D: BioGrid_Yeast |
RPS24 | 6229 | RPS27A | 6233 | pp | -- | int.I2D: YeastMedium |
RPS8 | 6202 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
RPS3A | 6189 | RPS6 | 6194 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0022627 | cytosolic small ribosomal subunit | 3.13e-38 | 5.10e-34 | 7.150 | 19 | 21 | 39 |
GO:0019058 | viral life cycle | 9.52e-34 | 1.55e-29 | 5.801 | 22 | 25 | 115 |
GO:0019083 | viral transcription | 6.27e-31 | 1.02e-26 | 6.095 | 19 | 22 | 81 |
GO:0006415 | translational termination | 2.86e-30 | 4.66e-26 | 5.992 | 19 | 22 | 87 |
GO:0006414 | translational elongation | 1.16e-29 | 1.89e-25 | 5.896 | 19 | 22 | 93 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.18e-28 | 1.93e-24 | 5.735 | 19 | 22 | 104 |
GO:0006413 | translational initiation | 1.68e-28 | 2.74e-24 | 5.476 | 20 | 27 | 131 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 7.81e-28 | 1.27e-23 | 5.602 | 19 | 22 | 114 |
GO:0003735 | structural constituent of ribosome | 5.75e-26 | 9.38e-22 | 5.295 | 19 | 24 | 141 |
GO:0016032 | viral process | 4.73e-24 | 7.71e-20 | 3.811 | 26 | 37 | 540 |
GO:0016071 | mRNA metabolic process | 1.11e-23 | 1.80e-19 | 4.708 | 20 | 29 | 223 |
GO:0006412 | translation | 3.22e-23 | 5.25e-19 | 4.632 | 20 | 29 | 235 |
GO:0016070 | RNA metabolic process | 8.86e-23 | 1.45e-18 | 4.561 | 20 | 29 | 247 |
GO:0005829 | cytosol | 1.13e-21 | 1.85e-17 | 2.222 | 41 | 74 | 2562 |
GO:0044267 | cellular protein metabolic process | 4.36e-18 | 7.11e-14 | 3.628 | 21 | 29 | 495 |
GO:0010467 | gene expression | 1.24e-16 | 2.02e-12 | 3.261 | 22 | 36 | 669 |
GO:0015935 | small ribosomal subunit | 2.71e-16 | 4.42e-12 | 7.100 | 8 | 9 | 17 |
GO:0044822 | poly(A) RNA binding | 1.85e-15 | 3.01e-11 | 2.757 | 25 | 42 | 1078 |
GO:0016020 | membrane | 2.07e-13 | 3.37e-09 | 2.225 | 28 | 48 | 1746 |
GO:0005925 | focal adhesion | 1.13e-12 | 1.85e-08 | 3.563 | 15 | 23 | 370 |
GO:0048205 | COPI coating of Golgi vesicle | 2.09e-12 | 3.40e-08 | 7.072 | 6 | 6 | 13 |
GO:0030126 | COPI vesicle coat | 2.09e-12 | 3.40e-08 | 7.072 | 6 | 6 | 13 |
GO:0061024 | membrane organization | 6.03e-11 | 9.83e-07 | 4.319 | 10 | 11 | 146 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 2.09e-10 | 3.40e-06 | 6.128 | 6 | 6 | 25 |
GO:0042274 | ribosomal small subunit biogenesis | 3.08e-10 | 5.03e-06 | 6.924 | 5 | 6 | 12 |
GO:0005840 | ribosome | 1.13e-09 | 1.84e-05 | 5.112 | 7 | 10 | 59 |
GO:0070062 | extracellular vesicular exosome | 1.43e-09 | 2.34e-05 | 1.698 | 28 | 51 | 2516 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3.81e-07 | 6.21e-03 | 7.450 | 3 | 3 | 5 |
GO:0006364 | rRNA processing | 9.06e-07 | 1.48e-02 | 4.187 | 6 | 8 | 96 |
GO:0000028 | ribosomal small subunit assembly | 1.33e-06 | 2.16e-02 | 6.965 | 3 | 3 | 7 |
GO:0019843 | rRNA binding | 2.06e-06 | 3.36e-02 | 5.432 | 4 | 4 | 27 |
GO:0005515 | protein binding | 1.37e-05 | 2.23e-01 | 0.816 | 37 | 87 | 6127 |
GO:0075733 | intracellular transport of virus | 2.51e-05 | 4.10e-01 | 5.685 | 3 | 3 | 17 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 2.51e-05 | 4.10e-01 | 5.685 | 3 | 3 | 17 |
GO:0006886 | intracellular protein transport | 2.72e-05 | 4.44e-01 | 3.337 | 6 | 6 | 173 |
GO:0051683 | establishment of Golgi localization | 3.46e-05 | 5.65e-01 | 7.602 | 2 | 2 | 3 |
GO:0000056 | ribosomal small subunit export from nucleus | 3.46e-05 | 5.65e-01 | 7.602 | 2 | 2 | 3 |
GO:0030529 | ribonucleoprotein complex | 4.38e-05 | 7.14e-01 | 3.676 | 5 | 8 | 114 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 5.63e-05 | 9.18e-01 | 5.313 | 3 | 5 | 22 |
GO:0030490 | maturation of SSU-rRNA | 6.91e-05 | 1.00e+00 | 7.187 | 2 | 2 | 4 |
GO:0072384 | organelle transport along microtubule | 6.91e-05 | 1.00e+00 | 7.187 | 2 | 2 | 4 |
GO:0034146 | toll-like receptor 5 signaling pathway | 7.20e-05 | 1.00e+00 | 4.165 | 4 | 5 | 65 |
GO:0034166 | toll-like receptor 10 signaling pathway | 7.20e-05 | 1.00e+00 | 4.165 | 4 | 5 | 65 |
GO:0005737 | cytoplasm | 8.91e-05 | 1.00e+00 | 0.985 | 27 | 65 | 3976 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 1.02e-04 | 1.00e+00 | 4.037 | 4 | 5 | 71 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 1.02e-04 | 1.00e+00 | 4.037 | 4 | 5 | 71 |
GO:0034162 | toll-like receptor 9 signaling pathway | 1.08e-04 | 1.00e+00 | 4.017 | 4 | 5 | 72 |
GO:0034134 | toll-like receptor 2 signaling pathway | 1.13e-04 | 1.00e+00 | 3.997 | 4 | 5 | 73 |
GO:0033119 | negative regulation of RNA splicing | 1.15e-04 | 1.00e+00 | 6.865 | 2 | 2 | 5 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 1.33e-04 | 1.00e+00 | 3.939 | 4 | 5 | 76 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 1.47e-04 | 1.00e+00 | 3.902 | 4 | 5 | 78 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 1.62e-04 | 1.00e+00 | 3.865 | 4 | 5 | 80 |
GO:0034138 | toll-like receptor 3 signaling pathway | 1.62e-04 | 1.00e+00 | 3.865 | 4 | 5 | 80 |
GO:0045182 | translation regulator activity | 1.72e-04 | 1.00e+00 | 6.602 | 2 | 2 | 6 |
GO:0005198 | structural molecule activity | 2.11e-04 | 1.00e+00 | 3.196 | 5 | 5 | 159 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 2.52e-04 | 1.00e+00 | 4.602 | 3 | 3 | 36 |
GO:0034142 | toll-like receptor 4 signaling pathway | 3.27e-04 | 1.00e+00 | 3.602 | 4 | 5 | 96 |
GO:0005730 | nucleolus | 4.08e-04 | 1.00e+00 | 1.376 | 15 | 36 | 1684 |
GO:0002224 | toll-like receptor signaling pathway | 5.29e-04 | 1.00e+00 | 3.419 | 4 | 5 | 109 |
GO:0043066 | negative regulation of apoptotic process | 6.65e-04 | 1.00e+00 | 2.236 | 7 | 14 | 433 |
GO:0007254 | JNK cascade | 7.09e-04 | 1.00e+00 | 4.100 | 3 | 3 | 51 |
GO:0019082 | viral protein processing | 7.47e-04 | 1.00e+00 | 5.602 | 2 | 2 | 12 |
GO:0051403 | stress-activated MAPK cascade | 8.38e-04 | 1.00e+00 | 4.017 | 3 | 4 | 54 |
GO:0032479 | regulation of type I interferon production | 8.80e-04 | 1.00e+00 | 5.487 | 2 | 2 | 13 |
GO:0071398 | cellular response to fatty acid | 8.80e-04 | 1.00e+00 | 5.487 | 2 | 2 | 13 |
GO:0016197 | endosomal transport | 1.03e-03 | 1.00e+00 | 3.914 | 3 | 3 | 58 |
GO:0032481 | positive regulation of type I interferon production | 1.20e-03 | 1.00e+00 | 3.841 | 3 | 3 | 61 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.24e-03 | 1.00e+00 | 3.089 | 4 | 6 | 137 |
GO:0005882 | intermediate filament | 1.50e-03 | 1.00e+00 | 3.728 | 3 | 3 | 66 |
GO:0019068 | virion assembly | 1.52e-03 | 1.00e+00 | 5.100 | 2 | 2 | 17 |
GO:0018105 | peptidyl-serine phosphorylation | 1.71e-03 | 1.00e+00 | 3.664 | 3 | 5 | 69 |
GO:0043015 | gamma-tubulin binding | 1.71e-03 | 1.00e+00 | 5.017 | 2 | 2 | 18 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.74e-03 | 1.00e+00 | 2.958 | 4 | 11 | 150 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.78e-03 | 1.00e+00 | 3.643 | 3 | 8 | 70 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.09e-03 | 1.00e+00 | 3.563 | 3 | 8 | 74 |
GO:0043473 | pigmentation | 2.11e-03 | 1.00e+00 | 4.865 | 2 | 2 | 20 |
GO:0043005 | neuron projection | 2.25e-03 | 1.00e+00 | 2.856 | 4 | 6 | 161 |
GO:0043065 | positive regulation of apoptotic process | 2.44e-03 | 1.00e+00 | 2.411 | 5 | 6 | 274 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 2.52e-03 | 1.00e+00 | 3.468 | 3 | 8 | 79 |
GO:0007220 | Notch receptor processing | 2.56e-03 | 1.00e+00 | 4.728 | 2 | 2 | 22 |
GO:0071222 | cellular response to lipopolysaccharide | 2.70e-03 | 1.00e+00 | 3.432 | 3 | 4 | 81 |
GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 3.30e-03 | 1.00e+00 | 4.543 | 2 | 2 | 25 |
GO:0005844 | polysome | 3.30e-03 | 1.00e+00 | 4.543 | 2 | 2 | 25 |
GO:2001286 | regulation of caveolin-mediated endocytosis | 3.43e-03 | 1.00e+00 | 8.187 | 1 | 1 | 1 |
GO:0071393 | cellular response to progesterone stimulus | 3.43e-03 | 1.00e+00 | 8.187 | 1 | 1 | 1 |
GO:0004588 | orotate phosphoribosyltransferase activity | 3.43e-03 | 1.00e+00 | 8.187 | 1 | 1 | 1 |
GO:0004590 | orotidine-5'-phosphate decarboxylase activity | 3.43e-03 | 1.00e+00 | 8.187 | 1 | 1 | 1 |
GO:0033176 | proton-transporting V-type ATPase complex | 3.43e-03 | 1.00e+00 | 8.187 | 1 | 1 | 1 |
GO:0004673 | protein histidine kinase activity | 3.43e-03 | 1.00e+00 | 8.187 | 1 | 1 | 1 |
GO:0022605 | oogenesis stage | 3.43e-03 | 1.00e+00 | 8.187 | 1 | 1 | 1 |
GO:0018106 | peptidyl-histidine phosphorylation | 3.43e-03 | 1.00e+00 | 8.187 | 1 | 1 | 1 |
GO:0033593 | BRCA2-MAGE-D1 complex | 3.43e-03 | 1.00e+00 | 8.187 | 1 | 1 | 1 |
GO:0021691 | cerebellar Purkinje cell layer maturation | 3.43e-03 | 1.00e+00 | 8.187 | 1 | 1 | 1 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 3.56e-03 | 1.00e+00 | 4.487 | 2 | 2 | 26 |
GO:0005978 | glycogen biosynthetic process | 3.56e-03 | 1.00e+00 | 4.487 | 2 | 2 | 26 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 3.56e-03 | 1.00e+00 | 4.487 | 2 | 2 | 26 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 4.15e-03 | 1.00e+00 | 2.610 | 4 | 5 | 191 |
GO:0001649 | osteoblast differentiation | 4.24e-03 | 1.00e+00 | 3.202 | 3 | 3 | 95 |
GO:0071456 | cellular response to hypoxia | 4.62e-03 | 1.00e+00 | 3.157 | 3 | 3 | 98 |
GO:0003924 | GTPase activity | 5.15e-03 | 1.00e+00 | 2.522 | 4 | 6 | 203 |
GO:0032480 | negative regulation of type I interferon production | 5.37e-03 | 1.00e+00 | 4.187 | 2 | 2 | 32 |
GO:0005634 | nucleus | 5.61e-03 | 1.00e+00 | 0.650 | 26 | 66 | 4828 |
GO:0034332 | adherens junction organization | 6.76e-03 | 1.00e+00 | 4.017 | 2 | 4 | 36 |
GO:0006184 | GTP catabolic process | 6.82e-03 | 1.00e+00 | 2.406 | 4 | 6 | 220 |
GO:0071987 | WD40-repeat domain binding | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 2 |
GO:0060661 | submandibular salivary gland formation | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 2 |
GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 2 |
GO:0002762 | negative regulation of myeloid leukocyte differentiation | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 2 |
GO:0071338 | positive regulation of hair follicle cell proliferation | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 2 |
GO:0048822 | enucleate erythrocyte development | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 2 |
GO:0072422 | signal transduction involved in DNA damage checkpoint | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 2 |
GO:0010632 | regulation of epithelial cell migration | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 2 |
GO:0001672 | regulation of chromatin assembly or disassembly | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 2 |
GO:0090135 | actin filament branching | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 2 |
GO:0060265 | positive regulation of respiratory burst involved in inflammatory response | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 2 |
GO:0003723 | RNA binding | 7.29e-03 | 1.00e+00 | 2.037 | 5 | 10 | 355 |
GO:0097190 | apoptotic signaling pathway | 7.38e-03 | 1.00e+00 | 2.914 | 3 | 3 | 116 |
GO:0000209 | protein polyubiquitination | 7.38e-03 | 1.00e+00 | 2.914 | 3 | 7 | 116 |
GO:0030218 | erythrocyte differentiation | 7.51e-03 | 1.00e+00 | 3.939 | 2 | 2 | 38 |
GO:0097191 | extrinsic apoptotic signaling pathway | 7.51e-03 | 1.00e+00 | 3.939 | 2 | 3 | 38 |
GO:0007249 | I-kappaB kinase/NF-kappaB signaling | 8.70e-03 | 1.00e+00 | 3.830 | 2 | 4 | 41 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 9.05e-03 | 1.00e+00 | 2.806 | 3 | 3 | 125 |
GO:0007219 | Notch signaling pathway | 9.05e-03 | 1.00e+00 | 2.806 | 3 | 4 | 125 |
GO:0003713 | transcription coactivator activity | 9.08e-03 | 1.00e+00 | 2.286 | 4 | 6 | 239 |
GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 9.54e-03 | 1.00e+00 | 3.761 | 2 | 2 | 43 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.01e-02 | 1.00e+00 | 2.750 | 3 | 4 | 130 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 1.03e-02 | 1.00e+00 | 6.602 | 1 | 1 | 3 |
GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding | 1.03e-02 | 1.00e+00 | 6.602 | 1 | 1 | 3 |
GO:0003161 | cardiac conduction system development | 1.03e-02 | 1.00e+00 | 6.602 | 1 | 1 | 3 |
GO:0090045 | positive regulation of deacetylase activity | 1.03e-02 | 1.00e+00 | 6.602 | 1 | 1 | 3 |
GO:0035033 | histone deacetylase regulator activity | 1.03e-02 | 1.00e+00 | 6.602 | 1 | 1 | 3 |
GO:2000017 | positive regulation of determination of dorsal identity | 1.03e-02 | 1.00e+00 | 6.602 | 1 | 1 | 3 |
GO:0010484 | H3 histone acetyltransferase activity | 1.03e-02 | 1.00e+00 | 6.602 | 1 | 1 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 1.03e-02 | 1.00e+00 | 6.602 | 1 | 1 | 3 |
GO:0050779 | RNA destabilization | 1.03e-02 | 1.00e+00 | 6.602 | 1 | 1 | 3 |
GO:0031084 | BLOC-2 complex | 1.03e-02 | 1.00e+00 | 6.602 | 1 | 1 | 3 |
GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity | 1.03e-02 | 1.00e+00 | 6.602 | 1 | 1 | 3 |
GO:0033146 | regulation of intracellular estrogen receptor signaling pathway | 1.03e-02 | 1.00e+00 | 6.602 | 1 | 1 | 3 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 1.03e-02 | 1.00e+00 | 6.602 | 1 | 1 | 3 |
GO:0004705 | JUN kinase activity | 1.03e-02 | 1.00e+00 | 6.602 | 1 | 1 | 3 |
GO:0060266 | negative regulation of respiratory burst involved in inflammatory response | 1.03e-02 | 1.00e+00 | 6.602 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 1.03e-02 | 1.00e+00 | 6.602 | 1 | 1 | 3 |
GO:0035690 | cellular response to drug | 1.27e-02 | 1.00e+00 | 3.543 | 2 | 3 | 50 |
GO:0007030 | Golgi organization | 1.27e-02 | 1.00e+00 | 3.543 | 2 | 3 | 50 |
GO:0034191 | apolipoprotein A-I receptor binding | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 1 | 4 |
GO:0007000 | nucleolus organization | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 2 | 4 |
GO:0048478 | replication fork protection | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 1 | 4 |
GO:0032463 | negative regulation of protein homooligomerization | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 1 | 4 |
GO:0051902 | negative regulation of mitochondrial depolarization | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 1 | 4 |
GO:0060020 | Bergmann glial cell differentiation | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 1 | 4 |
GO:0031062 | positive regulation of histone methylation | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 1 | 4 |
GO:0060684 | epithelial-mesenchymal cell signaling | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 1 | 4 |
GO:0070851 | growth factor receptor binding | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 1 | 4 |
GO:0051835 | positive regulation of synapse structural plasticity | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 1 | 4 |
GO:0006222 | UMP biosynthetic process | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 1 | 4 |
GO:0090231 | regulation of spindle checkpoint | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 1 | 4 |
GO:0007258 | JUN phosphorylation | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 1 | 4 |
GO:0048664 | neuron fate determination | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 1 | 4 |
GO:0033503 | HULC complex | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 1 | 4 |
GO:0045682 | regulation of epidermis development | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 1 | 4 |
GO:0004197 | cysteine-type endopeptidase activity | 1.37e-02 | 1.00e+00 | 3.487 | 2 | 2 | 52 |
GO:0031063 | regulation of histone deacetylation | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 1 | 4 |
GO:0031467 | Cul7-RING ubiquitin ligase complex | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 1 | 4 |
GO:0000055 | ribosomal large subunit export from nucleus | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 1 | 4 |
GO:0033625 | positive regulation of integrin activation | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 1 | 4 |
GO:0009991 | response to extracellular stimulus | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 1 | 4 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 1.42e-02 | 1.00e+00 | 2.094 | 4 | 5 | 273 |
GO:0010628 | positive regulation of gene expression | 1.45e-02 | 1.00e+00 | 2.553 | 3 | 4 | 149 |
GO:0030666 | endocytic vesicle membrane | 1.48e-02 | 1.00e+00 | 3.432 | 2 | 2 | 54 |
GO:0042981 | regulation of apoptotic process | 1.50e-02 | 1.00e+00 | 2.534 | 3 | 7 | 151 |
GO:2000641 | regulation of early endosome to late endosome transport | 1.70e-02 | 1.00e+00 | 5.865 | 1 | 1 | 5 |
GO:0036336 | dendritic cell migration | 1.70e-02 | 1.00e+00 | 5.865 | 1 | 1 | 5 |
GO:0033033 | negative regulation of myeloid cell apoptotic process | 1.70e-02 | 1.00e+00 | 5.865 | 1 | 1 | 5 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 1.70e-02 | 1.00e+00 | 5.865 | 1 | 1 | 5 |
GO:0051385 | response to mineralocorticoid | 1.70e-02 | 1.00e+00 | 5.865 | 1 | 1 | 5 |
GO:0005826 | actomyosin contractile ring | 1.70e-02 | 1.00e+00 | 5.865 | 1 | 1 | 5 |
GO:1902188 | positive regulation of viral release from host cell | 1.70e-02 | 1.00e+00 | 5.865 | 1 | 1 | 5 |
GO:0097300 | programmed necrotic cell death | 1.70e-02 | 1.00e+00 | 5.865 | 1 | 1 | 5 |
GO:0031256 | leading edge membrane | 1.70e-02 | 1.00e+00 | 5.865 | 1 | 1 | 5 |
GO:0031584 | activation of phospholipase D activity | 1.70e-02 | 1.00e+00 | 5.865 | 1 | 1 | 5 |
GO:0009404 | toxin metabolic process | 1.70e-02 | 1.00e+00 | 5.865 | 1 | 1 | 5 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 1.70e-02 | 1.00e+00 | 5.865 | 1 | 1 | 5 |
GO:0071803 | positive regulation of podosome assembly | 1.70e-02 | 1.00e+00 | 5.865 | 1 | 1 | 5 |
GO:0008543 | fibroblast growth factor receptor signaling pathway | 1.73e-02 | 1.00e+00 | 2.459 | 3 | 3 | 159 |
GO:0045087 | innate immune response | 1.85e-02 | 1.00e+00 | 1.505 | 6 | 11 | 616 |
GO:0006417 | regulation of translation | 1.98e-02 | 1.00e+00 | 3.210 | 2 | 4 | 63 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 2.03e-02 | 1.00e+00 | 3.187 | 2 | 2 | 64 |
GO:0050847 | progesterone receptor signaling pathway | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 1 | 6 |
GO:0007143 | female meiotic division | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 1 | 6 |
GO:0002309 | T cell proliferation involved in immune response | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 1 | 6 |
GO:0045056 | transcytosis | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 1 | 6 |
GO:0060789 | hair follicle placode formation | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 1 | 6 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 1 | 6 |
GO:0048554 | positive regulation of metalloenzyme activity | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 1 | 6 |
GO:0050792 | regulation of viral process | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 1 | 6 |
GO:0010485 | H4 histone acetyltransferase activity | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 1 | 6 |
GO:0002181 | cytoplasmic translation | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 2 | 6 |
GO:0019215 | intermediate filament binding | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 1 | 6 |
GO:0000974 | Prp19 complex | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 1 | 6 |
GO:0043196 | varicosity | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 1 | 6 |
GO:0006924 | activation-induced cell death of T cells | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 2 | 6 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 2.09e-02 | 1.00e+00 | 3.165 | 2 | 6 | 65 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.09e-02 | 1.00e+00 | 3.165 | 2 | 6 | 65 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 2.09e-02 | 1.00e+00 | 2.354 | 3 | 3 | 171 |
GO:0031295 | T cell costimulation | 2.22e-02 | 1.00e+00 | 3.121 | 2 | 3 | 67 |
GO:0030141 | secretory granule | 2.22e-02 | 1.00e+00 | 3.121 | 2 | 2 | 67 |
GO:0007049 | cell cycle | 2.28e-02 | 1.00e+00 | 2.304 | 3 | 4 | 177 |
GO:0003697 | single-stranded DNA binding | 2.34e-02 | 1.00e+00 | 3.079 | 2 | 4 | 69 |
GO:0010447 | response to acidic pH | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 1 | 7 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 1 | 7 |
GO:0060136 | embryonic process involved in female pregnancy | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 1 | 7 |
GO:0043497 | regulation of protein heterodimerization activity | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 1 | 7 |
GO:0050658 | RNA transport | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 1 | 7 |
GO:0048027 | mRNA 5'-UTR binding | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 1 | 7 |
GO:0007097 | nuclear migration | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 2 | 7 |
GO:0061512 | protein localization to cilium | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 1 | 7 |
GO:0003334 | keratinocyte development | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 1 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 1 | 7 |
GO:0034101 | erythrocyte homeostasis | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 1 | 7 |
GO:0010907 | positive regulation of glucose metabolic process | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 1 | 7 |
GO:0048193 | Golgi vesicle transport | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 1 | 7 |
GO:0030157 | pancreatic juice secretion | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 1 | 7 |
GO:0000930 | gamma-tubulin complex | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 1 | 7 |
GO:0019901 | protein kinase binding | 2.40e-02 | 1.00e+00 | 1.865 | 4 | 9 | 320 |
GO:0019904 | protein domain specific binding | 2.42e-02 | 1.00e+00 | 2.272 | 3 | 3 | 181 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 2.60e-02 | 1.00e+00 | 2.997 | 2 | 6 | 73 |
GO:0003729 | mRNA binding | 2.60e-02 | 1.00e+00 | 2.997 | 2 | 3 | 73 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 2.60e-02 | 1.00e+00 | 2.997 | 2 | 2 | 73 |
GO:0005525 | GTP binding | 2.60e-02 | 1.00e+00 | 1.830 | 4 | 6 | 328 |
GO:0047498 | calcium-dependent phospholipase A2 activity | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 1 | 8 |
GO:0039702 | viral budding via host ESCRT complex | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 1 | 8 |
GO:0006183 | GTP biosynthetic process | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 1 | 8 |
GO:0043114 | regulation of vascular permeability | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 1 | 8 |
GO:0045124 | regulation of bone resorption | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 1 | 8 |
GO:0051489 | regulation of filopodium assembly | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 1 | 8 |
GO:0033523 | histone H2B ubiquitination | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 1 | 8 |
GO:0007172 | signal complex assembly | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 1 | 8 |
GO:0003682 | chromatin binding | 2.75e-02 | 1.00e+00 | 1.803 | 4 | 4 | 334 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 2.87e-02 | 1.00e+00 | 2.920 | 2 | 6 | 77 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 2.87e-02 | 1.00e+00 | 2.920 | 2 | 4 | 77 |
GO:0005813 | centrosome | 2.88e-02 | 1.00e+00 | 1.782 | 4 | 9 | 339 |
GO:0007229 | integrin-mediated signaling pathway | 2.94e-02 | 1.00e+00 | 2.902 | 2 | 2 | 78 |
GO:0071732 | cellular response to nitric oxide | 3.05e-02 | 1.00e+00 | 5.017 | 1 | 1 | 9 |
GO:0006241 | CTP biosynthetic process | 3.05e-02 | 1.00e+00 | 5.017 | 1 | 1 | 9 |
GO:0014075 | response to amine | 3.05e-02 | 1.00e+00 | 5.017 | 1 | 1 | 9 |
GO:0034067 | protein localization to Golgi apparatus | 3.05e-02 | 1.00e+00 | 5.017 | 1 | 1 | 9 |
GO:0006228 | UTP biosynthetic process | 3.05e-02 | 1.00e+00 | 5.017 | 1 | 1 | 9 |
GO:0090136 | epithelial cell-cell adhesion | 3.05e-02 | 1.00e+00 | 5.017 | 1 | 2 | 9 |
GO:0047497 | mitochondrion transport along microtubule | 3.05e-02 | 1.00e+00 | 5.017 | 1 | 1 | 9 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 3.05e-02 | 1.00e+00 | 5.017 | 1 | 1 | 9 |
GO:0005031 | tumor necrosis factor-activated receptor activity | 3.05e-02 | 1.00e+00 | 5.017 | 1 | 1 | 9 |
GO:0010629 | negative regulation of gene expression | 3.08e-02 | 1.00e+00 | 2.865 | 2 | 2 | 80 |
GO:0051301 | cell division | 3.15e-02 | 1.00e+00 | 2.847 | 2 | 2 | 81 |
GO:0048471 | perinuclear region of cytoplasm | 3.32e-02 | 1.00e+00 | 1.478 | 5 | 9 | 523 |
GO:0045618 | positive regulation of keratinocyte differentiation | 3.38e-02 | 1.00e+00 | 4.865 | 1 | 1 | 10 |
GO:0010225 | response to UV-C | 3.38e-02 | 1.00e+00 | 4.865 | 1 | 1 | 10 |
GO:0070307 | lens fiber cell development | 3.38e-02 | 1.00e+00 | 4.865 | 1 | 1 | 10 |
GO:0005798 | Golgi-associated vesicle | 3.38e-02 | 1.00e+00 | 4.865 | 1 | 1 | 10 |
GO:0031274 | positive regulation of pseudopodium assembly | 3.38e-02 | 1.00e+00 | 4.865 | 1 | 2 | 10 |
GO:0006996 | organelle organization | 3.38e-02 | 1.00e+00 | 4.865 | 1 | 1 | 10 |
GO:0022407 | regulation of cell-cell adhesion | 3.38e-02 | 1.00e+00 | 4.865 | 1 | 1 | 10 |
GO:0060047 | heart contraction | 3.38e-02 | 1.00e+00 | 4.865 | 1 | 1 | 10 |
GO:0050852 | T cell receptor signaling pathway | 3.67e-02 | 1.00e+00 | 2.728 | 2 | 2 | 88 |
GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity | 3.71e-02 | 1.00e+00 | 4.728 | 1 | 1 | 11 |
GO:0051895 | negative regulation of focal adhesion assembly | 3.71e-02 | 1.00e+00 | 4.728 | 1 | 1 | 11 |
GO:0045120 | pronucleus | 3.71e-02 | 1.00e+00 | 4.728 | 1 | 1 | 11 |
GO:2000573 | positive regulation of DNA biosynthetic process | 3.71e-02 | 1.00e+00 | 4.728 | 1 | 2 | 11 |
GO:0051272 | positive regulation of cellular component movement | 3.71e-02 | 1.00e+00 | 4.728 | 1 | 1 | 11 |
GO:0045109 | intermediate filament organization | 3.71e-02 | 1.00e+00 | 4.728 | 1 | 1 | 11 |
GO:0060065 | uterus development | 3.71e-02 | 1.00e+00 | 4.728 | 1 | 1 | 11 |
GO:0010390 | histone monoubiquitination | 3.71e-02 | 1.00e+00 | 4.728 | 1 | 1 | 11 |
GO:0035518 | histone H2A monoubiquitination | 3.71e-02 | 1.00e+00 | 4.728 | 1 | 2 | 11 |
GO:0014002 | astrocyte development | 3.71e-02 | 1.00e+00 | 4.728 | 1 | 1 | 11 |
GO:0000187 | activation of MAPK activity | 3.82e-02 | 1.00e+00 | 2.695 | 2 | 3 | 90 |
GO:0061136 | regulation of proteasomal protein catabolic process | 4.04e-02 | 1.00e+00 | 4.602 | 1 | 1 | 12 |
GO:0007051 | spindle organization | 4.04e-02 | 1.00e+00 | 4.602 | 1 | 1 | 12 |
GO:0043149 | stress fiber assembly | 4.04e-02 | 1.00e+00 | 4.602 | 1 | 2 | 12 |
GO:0043249 | erythrocyte maturation | 4.04e-02 | 1.00e+00 | 4.602 | 1 | 1 | 12 |
GO:1903543 | positive regulation of exosomal secretion | 4.04e-02 | 1.00e+00 | 4.602 | 1 | 1 | 12 |
GO:0036150 | phosphatidylserine acyl-chain remodeling | 4.04e-02 | 1.00e+00 | 4.602 | 1 | 1 | 12 |
GO:1901214 | regulation of neuron death | 4.04e-02 | 1.00e+00 | 4.602 | 1 | 1 | 12 |
GO:0005200 | structural constituent of cytoskeleton | 4.05e-02 | 1.00e+00 | 2.648 | 2 | 6 | 93 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 4.13e-02 | 1.00e+00 | 2.632 | 2 | 7 | 94 |
GO:0043488 | regulation of mRNA stability | 4.37e-02 | 1.00e+00 | 4.487 | 1 | 1 | 13 |
GO:0001833 | inner cell mass cell proliferation | 4.37e-02 | 1.00e+00 | 4.487 | 1 | 1 | 13 |
GO:0031929 | TOR signaling | 4.37e-02 | 1.00e+00 | 4.487 | 1 | 1 | 13 |
GO:0005662 | DNA replication factor A complex | 4.37e-02 | 1.00e+00 | 4.487 | 1 | 1 | 13 |
GO:0036149 | phosphatidylinositol acyl-chain remodeling | 4.37e-02 | 1.00e+00 | 4.487 | 1 | 1 | 13 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 4.37e-02 | 1.00e+00 | 4.487 | 1 | 1 | 13 |
GO:0007067 | mitotic nuclear division | 4.48e-02 | 1.00e+00 | 1.920 | 3 | 7 | 231 |
GO:0035371 | microtubule plus-end | 4.70e-02 | 1.00e+00 | 4.380 | 1 | 1 | 14 |
GO:0031333 | negative regulation of protein complex assembly | 4.70e-02 | 1.00e+00 | 4.380 | 1 | 1 | 14 |
GO:0030705 | cytoskeleton-dependent intracellular transport | 4.70e-02 | 1.00e+00 | 4.380 | 1 | 1 | 14 |
GO:0050662 | coenzyme binding | 4.70e-02 | 1.00e+00 | 4.380 | 1 | 1 | 14 |
GO:0051298 | centrosome duplication | 4.70e-02 | 1.00e+00 | 4.380 | 1 | 1 | 14 |
GO:0071480 | cellular response to gamma radiation | 4.70e-02 | 1.00e+00 | 4.380 | 1 | 1 | 14 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 4.70e-02 | 1.00e+00 | 4.380 | 1 | 1 | 14 |
GO:0031996 | thioesterase binding | 4.70e-02 | 1.00e+00 | 4.380 | 1 | 1 | 14 |
GO:0006165 | nucleoside diphosphate phosphorylation | 4.70e-02 | 1.00e+00 | 4.380 | 1 | 1 | 14 |
GO:0032465 | regulation of cytokinesis | 4.70e-02 | 1.00e+00 | 4.380 | 1 | 1 | 14 |
GO:0000278 | mitotic cell cycle | 4.74e-02 | 1.00e+00 | 1.550 | 4 | 16 | 398 |
GO:0048477 | oogenesis | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 1 | 15 |
GO:0030131 | clathrin adaptor complex | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 1 | 15 |
GO:0030225 | macrophage differentiation | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 1 | 15 |
GO:0036148 | phosphatidylglycerol acyl-chain remodeling | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 1 | 15 |
GO:0004550 | nucleoside diphosphate kinase activity | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 1 | 15 |
GO:0048821 | erythrocyte development | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 2 | 15 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 1 | 15 |
GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 1 | 15 |
GO:0031369 | translation initiation factor binding | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 2 | 15 |
GO:0008585 | female gonad development | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 1 | 15 |
GO:0051233 | spindle midzone | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 2 | 15 |
GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 1 | 15 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 5.09e-02 | 1.00e+00 | 1.307 | 5 | 9 | 589 |
GO:0000139 | Golgi membrane | 5.11e-02 | 1.00e+00 | 1.515 | 4 | 7 | 408 |
GO:0014911 | positive regulation of smooth muscle cell migration | 5.35e-02 | 1.00e+00 | 4.187 | 1 | 1 | 16 |
GO:0048037 | cofactor binding | 5.35e-02 | 1.00e+00 | 4.187 | 1 | 1 | 16 |
GO:0042176 | regulation of protein catabolic process | 5.35e-02 | 1.00e+00 | 4.187 | 1 | 4 | 16 |
GO:2000811 | negative regulation of anoikis | 5.35e-02 | 1.00e+00 | 4.187 | 1 | 1 | 16 |
GO:0005212 | structural constituent of eye lens | 5.35e-02 | 1.00e+00 | 4.187 | 1 | 1 | 16 |
GO:0043025 | neuronal cell body | 5.65e-02 | 1.00e+00 | 1.783 | 3 | 5 | 254 |
GO:0002548 | monocyte chemotaxis | 5.68e-02 | 1.00e+00 | 4.100 | 1 | 1 | 17 |
GO:0007141 | male meiosis I | 5.68e-02 | 1.00e+00 | 4.100 | 1 | 1 | 17 |
GO:0030742 | GTP-dependent protein binding | 5.68e-02 | 1.00e+00 | 4.100 | 1 | 1 | 17 |
GO:0001556 | oocyte maturation | 5.68e-02 | 1.00e+00 | 4.100 | 1 | 1 | 17 |
GO:0070064 | proline-rich region binding | 6.00e-02 | 1.00e+00 | 4.017 | 1 | 1 | 18 |
GO:0006612 | protein targeting to membrane | 6.00e-02 | 1.00e+00 | 4.017 | 1 | 2 | 18 |
GO:0031954 | positive regulation of protein autophosphorylation | 6.00e-02 | 1.00e+00 | 4.017 | 1 | 1 | 18 |
GO:0015949 | nucleobase-containing small molecule interconversion | 6.00e-02 | 1.00e+00 | 4.017 | 1 | 1 | 18 |
GO:0010507 | negative regulation of autophagy | 6.00e-02 | 1.00e+00 | 4.017 | 1 | 1 | 18 |
GO:0036152 | phosphatidylethanolamine acyl-chain remodeling | 6.00e-02 | 1.00e+00 | 4.017 | 1 | 1 | 18 |
GO:0090316 | positive regulation of intracellular protein transport | 6.00e-02 | 1.00e+00 | 4.017 | 1 | 1 | 18 |
GO:0006281 | DNA repair | 6.20e-02 | 1.00e+00 | 1.728 | 3 | 5 | 264 |
GO:0006006 | glucose metabolic process | 6.29e-02 | 1.00e+00 | 2.292 | 2 | 4 | 119 |
GO:0006259 | DNA metabolic process | 6.33e-02 | 1.00e+00 | 3.939 | 1 | 1 | 19 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 6.33e-02 | 1.00e+00 | 3.939 | 1 | 1 | 19 |
GO:0007088 | regulation of mitosis | 6.33e-02 | 1.00e+00 | 3.939 | 1 | 1 | 19 |
GO:0010165 | response to X-ray | 6.33e-02 | 1.00e+00 | 3.939 | 1 | 1 | 19 |
GO:0017134 | fibroblast growth factor binding | 6.33e-02 | 1.00e+00 | 3.939 | 1 | 2 | 19 |
GO:0045453 | bone resorption | 6.33e-02 | 1.00e+00 | 3.939 | 1 | 1 | 19 |
GO:0031667 | response to nutrient levels | 6.33e-02 | 1.00e+00 | 3.939 | 1 | 1 | 19 |
GO:0032148 | activation of protein kinase B activity | 6.65e-02 | 1.00e+00 | 3.865 | 1 | 1 | 20 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 6.65e-02 | 1.00e+00 | 3.865 | 1 | 2 | 20 |
GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator | 6.65e-02 | 1.00e+00 | 3.865 | 1 | 1 | 20 |
GO:0043393 | regulation of protein binding | 6.65e-02 | 1.00e+00 | 3.865 | 1 | 2 | 20 |
GO:0007369 | gastrulation | 6.97e-02 | 1.00e+00 | 3.795 | 1 | 1 | 21 |
GO:0046847 | filopodium assembly | 6.97e-02 | 1.00e+00 | 3.795 | 1 | 1 | 21 |
GO:0051881 | regulation of mitochondrial membrane potential | 6.97e-02 | 1.00e+00 | 3.795 | 1 | 1 | 21 |
GO:0005794 | Golgi apparatus | 7.15e-02 | 1.00e+00 | 1.165 | 5 | 8 | 650 |
GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | 7.29e-02 | 1.00e+00 | 3.728 | 1 | 1 | 22 |
GO:0046686 | response to cadmium ion | 7.29e-02 | 1.00e+00 | 3.728 | 1 | 1 | 22 |
GO:0033574 | response to testosterone | 7.29e-02 | 1.00e+00 | 3.728 | 1 | 1 | 22 |
GO:0001106 | RNA polymerase II transcription corepressor activity | 7.29e-02 | 1.00e+00 | 3.728 | 1 | 1 | 22 |
GO:0031435 | mitogen-activated protein kinase kinase kinase binding | 7.29e-02 | 1.00e+00 | 3.728 | 1 | 1 | 22 |
GO:0036151 | phosphatidylcholine acyl-chain remodeling | 7.29e-02 | 1.00e+00 | 3.728 | 1 | 1 | 22 |
GO:0007052 | mitotic spindle organization | 7.29e-02 | 1.00e+00 | 3.728 | 1 | 1 | 22 |
GO:0009615 | response to virus | 7.54e-02 | 1.00e+00 | 2.143 | 2 | 4 | 132 |
GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 7.61e-02 | 1.00e+00 | 3.664 | 1 | 1 | 23 |
GO:0071944 | cell periphery | 7.61e-02 | 1.00e+00 | 3.664 | 1 | 1 | 23 |
GO:0045787 | positive regulation of cell cycle | 7.61e-02 | 1.00e+00 | 3.664 | 1 | 2 | 23 |
GO:0002040 | sprouting angiogenesis | 7.61e-02 | 1.00e+00 | 3.664 | 1 | 1 | 23 |
GO:0051017 | actin filament bundle assembly | 7.61e-02 | 1.00e+00 | 3.664 | 1 | 1 | 23 |
GO:0001892 | embryonic placenta development | 7.61e-02 | 1.00e+00 | 3.664 | 1 | 1 | 23 |
GO:0051297 | centrosome organization | 7.61e-02 | 1.00e+00 | 3.664 | 1 | 2 | 23 |
GO:0031982 | vesicle | 7.73e-02 | 1.00e+00 | 2.121 | 2 | 2 | 134 |
GO:0007264 | small GTPase mediated signal transduction | 7.74e-02 | 1.00e+00 | 1.592 | 3 | 7 | 290 |
GO:0008135 | translation factor activity, nucleic acid binding | 7.92e-02 | 1.00e+00 | 3.602 | 1 | 4 | 24 |
GO:0007163 | establishment or maintenance of cell polarity | 7.92e-02 | 1.00e+00 | 3.602 | 1 | 2 | 24 |
GO:0006206 | pyrimidine nucleobase metabolic process | 7.92e-02 | 1.00e+00 | 3.602 | 1 | 1 | 24 |
GO:0051602 | response to electrical stimulus | 7.92e-02 | 1.00e+00 | 3.602 | 1 | 1 | 24 |
GO:0005654 | nucleoplasm | 7.94e-02 | 1.00e+00 | 0.898 | 7 | 26 | 1095 |
GO:0006611 | protein export from nucleus | 8.24e-02 | 1.00e+00 | 3.543 | 1 | 1 | 25 |
GO:0006654 | phosphatidic acid biosynthetic process | 8.24e-02 | 1.00e+00 | 3.543 | 1 | 1 | 25 |
GO:0031519 | PcG protein complex | 8.24e-02 | 1.00e+00 | 3.543 | 1 | 1 | 25 |
GO:0050715 | positive regulation of cytokine secretion | 8.24e-02 | 1.00e+00 | 3.543 | 1 | 1 | 25 |
GO:0007569 | cell aging | 8.24e-02 | 1.00e+00 | 3.543 | 1 | 1 | 25 |
GO:0048705 | skeletal system morphogenesis | 8.24e-02 | 1.00e+00 | 3.543 | 1 | 1 | 25 |
GO:0043234 | protein complex | 8.37e-02 | 1.00e+00 | 1.543 | 3 | 9 | 300 |
GO:0045931 | positive regulation of mitotic cell cycle | 8.55e-02 | 1.00e+00 | 3.487 | 1 | 2 | 26 |
GO:0000045 | autophagic vacuole assembly | 8.55e-02 | 1.00e+00 | 3.487 | 1 | 1 | 26 |
GO:0045859 | regulation of protein kinase activity | 8.55e-02 | 1.00e+00 | 3.487 | 1 | 1 | 26 |
GO:1900740 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 8.55e-02 | 1.00e+00 | 3.487 | 1 | 1 | 26 |
GO:0045893 | positive regulation of transcription, DNA-templated | 8.56e-02 | 1.00e+00 | 1.259 | 4 | 8 | 487 |
GO:0008286 | insulin receptor signaling pathway | 8.75e-02 | 1.00e+00 | 2.017 | 2 | 4 | 144 |
GO:0051149 | positive regulation of muscle cell differentiation | 8.87e-02 | 1.00e+00 | 3.432 | 1 | 2 | 27 |
GO:0032720 | negative regulation of tumor necrosis factor production | 8.87e-02 | 1.00e+00 | 3.432 | 1 | 1 | 27 |
GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway | 8.87e-02 | 1.00e+00 | 3.432 | 1 | 1 | 27 |
GO:0031424 | keratinization | 8.87e-02 | 1.00e+00 | 3.432 | 1 | 1 | 27 |
GO:0001103 | RNA polymerase II repressing transcription factor binding | 8.87e-02 | 1.00e+00 | 3.432 | 1 | 1 | 27 |
GO:0030331 | estrogen receptor binding | 8.87e-02 | 1.00e+00 | 3.432 | 1 | 1 | 27 |
GO:0045184 | establishment of protein localization | 8.87e-02 | 1.00e+00 | 3.432 | 1 | 2 | 27 |
GO:0051258 | protein polymerization | 8.87e-02 | 1.00e+00 | 3.432 | 1 | 1 | 27 |
GO:0031069 | hair follicle morphogenesis | 8.87e-02 | 1.00e+00 | 3.432 | 1 | 1 | 27 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 9.16e-02 | 1.00e+00 | 1.978 | 2 | 3 | 148 |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | 9.18e-02 | 1.00e+00 | 3.380 | 1 | 1 | 28 |
GO:0032467 | positive regulation of cytokinesis | 9.18e-02 | 1.00e+00 | 3.380 | 1 | 1 | 28 |
GO:0043967 | histone H4 acetylation | 9.18e-02 | 1.00e+00 | 3.380 | 1 | 2 | 28 |
GO:0007017 | microtubule-based process | 9.18e-02 | 1.00e+00 | 3.380 | 1 | 2 | 28 |
GO:0042626 | ATPase activity, coupled to transmembrane movement of substances | 9.18e-02 | 1.00e+00 | 3.380 | 1 | 1 | 28 |
GO:0031252 | cell leading edge | 9.49e-02 | 1.00e+00 | 3.329 | 1 | 3 | 29 |
GO:0019005 | SCF ubiquitin ligase complex | 9.49e-02 | 1.00e+00 | 3.329 | 1 | 1 | 29 |
GO:0003730 | mRNA 3'-UTR binding | 9.49e-02 | 1.00e+00 | 3.329 | 1 | 1 | 29 |
GO:0034605 | cellular response to heat | 9.49e-02 | 1.00e+00 | 3.329 | 1 | 1 | 29 |
GO:0072686 | mitotic spindle | 9.49e-02 | 1.00e+00 | 3.329 | 1 | 1 | 29 |
GO:0010332 | response to gamma radiation | 9.49e-02 | 1.00e+00 | 3.329 | 1 | 2 | 29 |
GO:0010977 | negative regulation of neuron projection development | 9.81e-02 | 1.00e+00 | 3.280 | 1 | 2 | 30 |
GO:0051262 | protein tetramerization | 9.81e-02 | 1.00e+00 | 3.280 | 1 | 1 | 30 |
GO:0042254 | ribosome biogenesis | 9.81e-02 | 1.00e+00 | 3.280 | 1 | 1 | 30 |
GO:0007346 | regulation of mitotic cell cycle | 9.81e-02 | 1.00e+00 | 3.280 | 1 | 3 | 30 |
GO:0046875 | ephrin receptor binding | 9.81e-02 | 1.00e+00 | 3.280 | 1 | 2 | 30 |
GO:0042169 | SH2 domain binding | 9.81e-02 | 1.00e+00 | 3.280 | 1 | 1 | 30 |
GO:0031647 | regulation of protein stability | 9.81e-02 | 1.00e+00 | 3.280 | 1 | 1 | 30 |
GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 9.81e-02 | 1.00e+00 | 3.280 | 1 | 1 | 30 |
GO:0040018 | positive regulation of multicellular organism growth | 9.81e-02 | 1.00e+00 | 3.280 | 1 | 1 | 30 |
GO:0070555 | response to interleukin-1 | 1.01e-01 | 1.00e+00 | 3.233 | 1 | 1 | 31 |
GO:0010008 | endosome membrane | 1.01e-01 | 1.00e+00 | 1.892 | 2 | 2 | 157 |
GO:0007093 | mitotic cell cycle checkpoint | 1.01e-01 | 1.00e+00 | 3.233 | 1 | 2 | 31 |
GO:0033572 | transferrin transport | 1.04e-01 | 1.00e+00 | 3.187 | 1 | 1 | 32 |
GO:0015992 | proton transport | 1.04e-01 | 1.00e+00 | 3.187 | 1 | 1 | 32 |
GO:0051219 | phosphoprotein binding | 1.04e-01 | 1.00e+00 | 3.187 | 1 | 4 | 32 |
GO:0008022 | protein C-terminus binding | 1.06e-01 | 1.00e+00 | 1.856 | 2 | 4 | 161 |
GO:0032091 | negative regulation of protein binding | 1.07e-01 | 1.00e+00 | 3.143 | 1 | 1 | 33 |
GO:0005158 | insulin receptor binding | 1.07e-01 | 1.00e+00 | 3.143 | 1 | 2 | 33 |
GO:0033077 | T cell differentiation in thymus | 1.07e-01 | 1.00e+00 | 3.143 | 1 | 1 | 33 |
GO:0048812 | neuron projection morphogenesis | 1.07e-01 | 1.00e+00 | 3.143 | 1 | 1 | 33 |
GO:0001890 | placenta development | 1.10e-01 | 1.00e+00 | 3.100 | 1 | 1 | 34 |
GO:0097110 | scaffold protein binding | 1.10e-01 | 1.00e+00 | 3.100 | 1 | 1 | 34 |
GO:0042692 | muscle cell differentiation | 1.10e-01 | 1.00e+00 | 3.100 | 1 | 2 | 34 |
GO:0051701 | interaction with host | 1.10e-01 | 1.00e+00 | 3.100 | 1 | 1 | 34 |
GO:0034220 | ion transmembrane transport | 1.12e-01 | 1.00e+00 | 1.803 | 2 | 2 | 167 |
GO:0071333 | cellular response to glucose stimulus | 1.13e-01 | 1.00e+00 | 3.058 | 1 | 2 | 35 |
GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway | 1.13e-01 | 1.00e+00 | 3.058 | 1 | 1 | 35 |
GO:0030178 | negative regulation of Wnt signaling pathway | 1.17e-01 | 1.00e+00 | 3.017 | 1 | 1 | 36 |
GO:0071560 | cellular response to transforming growth factor beta stimulus | 1.17e-01 | 1.00e+00 | 3.017 | 1 | 1 | 36 |
GO:0016301 | kinase activity | 1.20e-01 | 1.00e+00 | 2.978 | 1 | 2 | 37 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.20e-01 | 1.00e+00 | 2.978 | 1 | 2 | 37 |
GO:0018107 | peptidyl-threonine phosphorylation | 1.20e-01 | 1.00e+00 | 2.978 | 1 | 1 | 37 |
GO:0032880 | regulation of protein localization | 1.20e-01 | 1.00e+00 | 2.978 | 1 | 1 | 37 |
GO:0050681 | androgen receptor binding | 1.23e-01 | 1.00e+00 | 2.939 | 1 | 2 | 38 |
GO:0030049 | muscle filament sliding | 1.23e-01 | 1.00e+00 | 2.939 | 1 | 2 | 38 |
GO:0045740 | positive regulation of DNA replication | 1.23e-01 | 1.00e+00 | 2.939 | 1 | 1 | 38 |
GO:0090382 | phagosome maturation | 1.23e-01 | 1.00e+00 | 2.939 | 1 | 1 | 38 |
GO:0008047 | enzyme activator activity | 1.26e-01 | 1.00e+00 | 2.902 | 1 | 1 | 39 |
GO:0032092 | positive regulation of protein binding | 1.26e-01 | 1.00e+00 | 2.902 | 1 | 1 | 39 |
GO:0021766 | hippocampus development | 1.26e-01 | 1.00e+00 | 2.902 | 1 | 3 | 39 |
GO:0007595 | lactation | 1.26e-01 | 1.00e+00 | 2.902 | 1 | 1 | 39 |
GO:0031625 | ubiquitin protein ligase binding | 1.27e-01 | 1.00e+00 | 1.695 | 2 | 4 | 180 |
GO:0042542 | response to hydrogen peroxide | 1.29e-01 | 1.00e+00 | 2.865 | 1 | 1 | 40 |
GO:0005764 | lysosome | 1.29e-01 | 1.00e+00 | 1.679 | 2 | 2 | 182 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.31e-01 | 1.00e+00 | 1.664 | 2 | 5 | 184 |
GO:0005881 | cytoplasmic microtubule | 1.32e-01 | 1.00e+00 | 2.830 | 1 | 1 | 41 |
GO:0070301 | cellular response to hydrogen peroxide | 1.32e-01 | 1.00e+00 | 2.830 | 1 | 1 | 41 |
GO:0030521 | androgen receptor signaling pathway | 1.32e-01 | 1.00e+00 | 2.830 | 1 | 3 | 41 |
GO:0045785 | positive regulation of cell adhesion | 1.32e-01 | 1.00e+00 | 2.830 | 1 | 1 | 41 |
GO:0006915 | apoptotic process | 1.32e-01 | 1.00e+00 | 1.030 | 4 | 9 | 571 |
GO:0071363 | cellular response to growth factor stimulus | 1.35e-01 | 1.00e+00 | 2.795 | 1 | 1 | 42 |
GO:0042147 | retrograde transport, endosome to Golgi | 1.35e-01 | 1.00e+00 | 2.795 | 1 | 1 | 42 |
GO:0005902 | microvillus | 1.35e-01 | 1.00e+00 | 2.795 | 1 | 1 | 42 |
GO:0004715 | non-membrane spanning protein tyrosine kinase activity | 1.35e-01 | 1.00e+00 | 2.795 | 1 | 1 | 42 |
GO:0004402 | histone acetyltransferase activity | 1.38e-01 | 1.00e+00 | 2.761 | 1 | 1 | 43 |
GO:0007286 | spermatid development | 1.41e-01 | 1.00e+00 | 2.728 | 1 | 1 | 44 |
GO:0005080 | protein kinase C binding | 1.41e-01 | 1.00e+00 | 2.728 | 1 | 1 | 44 |
GO:0034613 | cellular protein localization | 1.41e-01 | 1.00e+00 | 2.728 | 1 | 2 | 44 |
GO:0043966 | histone H3 acetylation | 1.43e-01 | 1.00e+00 | 2.695 | 1 | 1 | 45 |
GO:0009411 | response to UV | 1.43e-01 | 1.00e+00 | 2.695 | 1 | 2 | 45 |
GO:0051591 | response to cAMP | 1.43e-01 | 1.00e+00 | 2.695 | 1 | 1 | 45 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.44e-01 | 1.00e+00 | 0.845 | 5 | 11 | 811 |
GO:0044297 | cell body | 1.46e-01 | 1.00e+00 | 2.664 | 1 | 1 | 46 |
GO:0043525 | positive regulation of neuron apoptotic process | 1.46e-01 | 1.00e+00 | 2.664 | 1 | 2 | 46 |
GO:0045727 | positive regulation of translation | 1.46e-01 | 1.00e+00 | 2.664 | 1 | 1 | 46 |
GO:0021762 | substantia nigra development | 1.46e-01 | 1.00e+00 | 2.664 | 1 | 2 | 46 |
GO:0043406 | positive regulation of MAP kinase activity | 1.49e-01 | 1.00e+00 | 2.632 | 1 | 1 | 47 |
GO:0006921 | cellular component disassembly involved in execution phase of apoptosis | 1.49e-01 | 1.00e+00 | 2.632 | 1 | 1 | 47 |
GO:0008344 | adult locomotory behavior | 1.49e-01 | 1.00e+00 | 2.632 | 1 | 2 | 47 |
GO:0008284 | positive regulation of cell proliferation | 1.51e-01 | 1.00e+00 | 1.157 | 3 | 7 | 392 |
GO:0006950 | response to stress | 1.52e-01 | 1.00e+00 | 2.602 | 1 | 1 | 48 |
GO:0019003 | GDP binding | 1.52e-01 | 1.00e+00 | 2.602 | 1 | 1 | 48 |
GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage | 1.55e-01 | 1.00e+00 | 2.572 | 1 | 2 | 49 |
GO:0005070 | SH3/SH2 adaptor activity | 1.55e-01 | 1.00e+00 | 2.572 | 1 | 1 | 49 |
GO:0045111 | intermediate filament cytoskeleton | 1.55e-01 | 1.00e+00 | 2.572 | 1 | 1 | 49 |
GO:0003743 | translation initiation factor activity | 1.55e-01 | 1.00e+00 | 2.572 | 1 | 5 | 49 |
GO:0001948 | glycoprotein binding | 1.58e-01 | 1.00e+00 | 2.543 | 1 | 2 | 50 |
GO:0000910 | cytokinesis | 1.61e-01 | 1.00e+00 | 2.515 | 1 | 2 | 51 |
GO:0090263 | positive regulation of canonical Wnt signaling pathway | 1.61e-01 | 1.00e+00 | 2.515 | 1 | 1 | 51 |
GO:0030900 | forebrain development | 1.61e-01 | 1.00e+00 | 2.515 | 1 | 1 | 51 |
GO:0008202 | steroid metabolic process | 1.64e-01 | 1.00e+00 | 2.487 | 1 | 1 | 52 |
GO:0016042 | lipid catabolic process | 1.64e-01 | 1.00e+00 | 2.487 | 1 | 2 | 52 |
GO:0006952 | defense response | 1.67e-01 | 1.00e+00 | 2.459 | 1 | 1 | 53 |
GO:0030175 | filopodium | 1.67e-01 | 1.00e+00 | 2.459 | 1 | 2 | 53 |
GO:0003725 | double-stranded RNA binding | 1.70e-01 | 1.00e+00 | 2.432 | 1 | 2 | 54 |
GO:0009612 | response to mechanical stimulus | 1.70e-01 | 1.00e+00 | 2.432 | 1 | 1 | 54 |
GO:0050679 | positive regulation of epithelial cell proliferation | 1.70e-01 | 1.00e+00 | 2.432 | 1 | 2 | 54 |
GO:0097193 | intrinsic apoptotic signaling pathway | 1.73e-01 | 1.00e+00 | 2.406 | 1 | 2 | 55 |
GO:0002039 | p53 binding | 1.73e-01 | 1.00e+00 | 2.406 | 1 | 1 | 55 |
GO:0008233 | peptidase activity | 1.73e-01 | 1.00e+00 | 2.406 | 1 | 1 | 55 |
GO:0046330 | positive regulation of JNK cascade | 1.73e-01 | 1.00e+00 | 2.406 | 1 | 1 | 55 |
GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment | 1.78e-01 | 1.00e+00 | 2.354 | 1 | 1 | 57 |
GO:0006879 | cellular iron ion homeostasis | 1.78e-01 | 1.00e+00 | 2.354 | 1 | 2 | 57 |
GO:0000724 | double-strand break repair via homologous recombination | 1.78e-01 | 1.00e+00 | 2.354 | 1 | 2 | 57 |
GO:0030097 | hemopoiesis | 1.81e-01 | 1.00e+00 | 2.329 | 1 | 1 | 58 |
GO:0005643 | nuclear pore | 1.84e-01 | 1.00e+00 | 2.304 | 1 | 1 | 59 |
GO:0050728 | negative regulation of inflammatory response | 1.87e-01 | 1.00e+00 | 2.280 | 1 | 2 | 60 |
GO:0019221 | cytokine-mediated signaling pathway | 1.87e-01 | 1.00e+00 | 1.342 | 2 | 5 | 230 |
GO:0010976 | positive regulation of neuron projection development | 1.87e-01 | 1.00e+00 | 2.280 | 1 | 2 | 60 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 1.89e-01 | 1.00e+00 | 2.256 | 1 | 1 | 61 |
GO:0006302 | double-strand break repair | 1.92e-01 | 1.00e+00 | 2.233 | 1 | 2 | 62 |
GO:0001078 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 1.92e-01 | 1.00e+00 | 2.233 | 1 | 1 | 62 |
GO:0000151 | ubiquitin ligase complex | 1.95e-01 | 1.00e+00 | 2.210 | 1 | 1 | 63 |
GO:0005901 | caveola | 1.95e-01 | 1.00e+00 | 2.210 | 1 | 1 | 63 |
GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 1.95e-01 | 1.00e+00 | 2.210 | 1 | 2 | 63 |
GO:0007059 | chromosome segregation | 1.98e-01 | 1.00e+00 | 2.187 | 1 | 3 | 64 |
GO:0032869 | cellular response to insulin stimulus | 1.98e-01 | 1.00e+00 | 2.187 | 1 | 2 | 64 |
GO:0016491 | oxidoreductase activity | 2.01e-01 | 1.00e+00 | 2.165 | 1 | 1 | 65 |
GO:0071260 | cellular response to mechanical stimulus | 2.03e-01 | 1.00e+00 | 2.143 | 1 | 3 | 66 |
GO:0043202 | lysosomal lumen | 2.03e-01 | 1.00e+00 | 2.143 | 1 | 1 | 66 |
GO:0006289 | nucleotide-excision repair | 2.12e-01 | 1.00e+00 | 2.079 | 1 | 1 | 69 |
GO:0035264 | multicellular organism growth | 2.14e-01 | 1.00e+00 | 2.058 | 1 | 1 | 70 |
GO:0042393 | histone binding | 2.17e-01 | 1.00e+00 | 2.037 | 1 | 1 | 71 |
GO:0001503 | ossification | 2.17e-01 | 1.00e+00 | 2.037 | 1 | 2 | 71 |
GO:0004842 | ubiquitin-protein transferase activity | 2.19e-01 | 1.00e+00 | 1.187 | 2 | 3 | 256 |
GO:0000785 | chromatin | 2.22e-01 | 1.00e+00 | 1.997 | 1 | 2 | 73 |
GO:0042826 | histone deacetylase binding | 2.25e-01 | 1.00e+00 | 1.978 | 1 | 1 | 74 |
GO:0002020 | protease binding | 2.25e-01 | 1.00e+00 | 1.978 | 1 | 1 | 74 |
GO:0007265 | Ras protein signal transduction | 2.28e-01 | 1.00e+00 | 1.958 | 1 | 3 | 75 |
GO:0051897 | positive regulation of protein kinase B signaling | 2.28e-01 | 1.00e+00 | 1.958 | 1 | 1 | 75 |
GO:0060070 | canonical Wnt signaling pathway | 2.28e-01 | 1.00e+00 | 1.958 | 1 | 2 | 75 |
GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding | 2.28e-01 | 1.00e+00 | 1.958 | 1 | 1 | 75 |
GO:0046474 | glycerophospholipid biosynthetic process | 2.30e-01 | 1.00e+00 | 1.939 | 1 | 2 | 76 |
GO:0044325 | ion channel binding | 2.33e-01 | 1.00e+00 | 1.920 | 1 | 3 | 77 |
GO:0006914 | autophagy | 2.33e-01 | 1.00e+00 | 1.920 | 1 | 1 | 77 |
GO:0008584 | male gonad development | 2.33e-01 | 1.00e+00 | 1.920 | 1 | 1 | 77 |
GO:0071013 | catalytic step 2 spliceosome | 2.38e-01 | 1.00e+00 | 1.883 | 1 | 1 | 79 |
GO:0031902 | late endosome membrane | 2.41e-01 | 1.00e+00 | 1.865 | 1 | 1 | 80 |
GO:0007565 | female pregnancy | 2.41e-01 | 1.00e+00 | 1.865 | 1 | 1 | 80 |
GO:0005975 | carbohydrate metabolic process | 2.42e-01 | 1.00e+00 | 1.089 | 2 | 3 | 274 |
GO:0007283 | spermatogenesis | 2.45e-01 | 1.00e+00 | 1.079 | 2 | 2 | 276 |
GO:0045177 | apical part of cell | 2.46e-01 | 1.00e+00 | 1.830 | 1 | 1 | 82 |
GO:0001726 | ruffle | 2.46e-01 | 1.00e+00 | 1.830 | 1 | 1 | 82 |
GO:0004713 | protein tyrosine kinase activity | 2.46e-01 | 1.00e+00 | 1.830 | 1 | 1 | 82 |
GO:0030336 | negative regulation of cell migration | 2.49e-01 | 1.00e+00 | 1.812 | 1 | 2 | 83 |
GO:0005929 | cilium | 2.51e-01 | 1.00e+00 | 1.795 | 1 | 2 | 84 |
GO:0005179 | hormone activity | 2.51e-01 | 1.00e+00 | 1.795 | 1 | 1 | 84 |
GO:0055085 | transmembrane transport | 2.58e-01 | 1.00e+00 | 0.766 | 3 | 3 | 514 |
GO:0019899 | enzyme binding | 2.60e-01 | 1.00e+00 | 1.017 | 2 | 5 | 288 |
GO:0042593 | glucose homeostasis | 2.64e-01 | 1.00e+00 | 1.711 | 1 | 1 | 89 |
GO:0042384 | cilium assembly | 2.67e-01 | 1.00e+00 | 1.695 | 1 | 2 | 90 |
GO:0005777 | peroxisome | 2.67e-01 | 1.00e+00 | 1.695 | 1 | 1 | 90 |
GO:0000922 | spindle pole | 2.69e-01 | 1.00e+00 | 1.679 | 1 | 5 | 91 |
GO:0016337 | single organismal cell-cell adhesion | 2.72e-01 | 1.00e+00 | 1.664 | 1 | 2 | 92 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 2.72e-01 | 1.00e+00 | 1.664 | 1 | 3 | 92 |
GO:0006928 | cellular component movement | 2.72e-01 | 1.00e+00 | 1.664 | 1 | 4 | 92 |
GO:0016363 | nuclear matrix | 2.72e-01 | 1.00e+00 | 1.664 | 1 | 4 | 92 |
GO:0042470 | melanosome | 2.72e-01 | 1.00e+00 | 1.664 | 1 | 2 | 92 |
GO:0005770 | late endosome | 2.77e-01 | 1.00e+00 | 1.632 | 1 | 1 | 94 |
GO:0007010 | cytoskeleton organization | 2.82e-01 | 1.00e+00 | 1.602 | 1 | 1 | 96 |
GO:0044281 | small molecule metabolic process | 2.83e-01 | 1.00e+00 | 0.433 | 6 | 16 | 1295 |
GO:0005178 | integrin binding | 2.84e-01 | 1.00e+00 | 1.587 | 1 | 1 | 97 |
GO:0016568 | chromatin modification | 2.89e-01 | 1.00e+00 | 1.558 | 1 | 2 | 99 |
GO:0005856 | cytoskeleton | 2.89e-01 | 1.00e+00 | 0.906 | 2 | 6 | 311 |
GO:0005739 | mitochondrion | 2.89e-01 | 1.00e+00 | 0.478 | 5 | 10 | 1046 |
GO:0004674 | protein serine/threonine kinase activity | 2.90e-01 | 1.00e+00 | 0.902 | 2 | 6 | 312 |
GO:0035556 | intracellular signal transduction | 2.97e-01 | 1.00e+00 | 0.879 | 2 | 5 | 317 |
GO:0014069 | postsynaptic density | 3.06e-01 | 1.00e+00 | 1.459 | 1 | 3 | 106 |
GO:0007411 | axon guidance | 3.10e-01 | 1.00e+00 | 0.834 | 2 | 3 | 327 |
GO:0030496 | midbody | 3.13e-01 | 1.00e+00 | 1.419 | 1 | 4 | 109 |
GO:0043231 | intracellular membrane-bounded organelle | 3.16e-01 | 1.00e+00 | 0.812 | 2 | 3 | 332 |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 3.16e-01 | 1.00e+00 | 1.406 | 1 | 1 | 110 |
GO:0005815 | microtubule organizing center | 3.16e-01 | 1.00e+00 | 1.406 | 1 | 4 | 110 |
GO:0050900 | leukocyte migration | 3.18e-01 | 1.00e+00 | 1.393 | 1 | 1 | 111 |
GO:0020037 | heme binding | 3.18e-01 | 1.00e+00 | 1.393 | 1 | 1 | 111 |
GO:0015630 | microtubule cytoskeleton | 3.20e-01 | 1.00e+00 | 1.380 | 1 | 4 | 112 |
GO:0005819 | spindle | 3.25e-01 | 1.00e+00 | 1.354 | 1 | 4 | 114 |
GO:0005802 | trans-Golgi network | 3.30e-01 | 1.00e+00 | 1.329 | 1 | 2 | 116 |
GO:0032496 | response to lipopolysaccharide | 3.44e-01 | 1.00e+00 | 1.256 | 1 | 1 | 122 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 3.46e-01 | 1.00e+00 | 1.245 | 1 | 3 | 123 |
GO:0007568 | aging | 3.46e-01 | 1.00e+00 | 1.245 | 1 | 2 | 123 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 3.55e-01 | 1.00e+00 | 1.198 | 1 | 3 | 127 |
GO:0030036 | actin cytoskeleton organization | 3.59e-01 | 1.00e+00 | 1.176 | 1 | 3 | 129 |
GO:0030027 | lamellipodium | 3.61e-01 | 1.00e+00 | 1.165 | 1 | 3 | 130 |
GO:0046983 | protein dimerization activity | 3.64e-01 | 1.00e+00 | 1.154 | 1 | 3 | 131 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 3.68e-01 | 1.00e+00 | 1.132 | 1 | 1 | 133 |
GO:0006644 | phospholipid metabolic process | 3.77e-01 | 1.00e+00 | 1.089 | 1 | 3 | 137 |
GO:0007155 | cell adhesion | 3.81e-01 | 1.00e+00 | 0.602 | 2 | 3 | 384 |
GO:0016055 | Wnt signaling pathway | 3.85e-01 | 1.00e+00 | 1.048 | 1 | 3 | 141 |
GO:0005911 | cell-cell junction | 3.87e-01 | 1.00e+00 | 1.037 | 1 | 2 | 142 |
GO:0006457 | protein folding | 4.02e-01 | 1.00e+00 | 0.968 | 1 | 3 | 149 |
GO:0006508 | proteolysis | 4.13e-01 | 1.00e+00 | 0.508 | 2 | 2 | 410 |
GO:0006974 | cellular response to DNA damage stimulus | 4.21e-01 | 1.00e+00 | 0.883 | 1 | 3 | 158 |
GO:0046777 | protein autophosphorylation | 4.21e-01 | 1.00e+00 | 0.883 | 1 | 1 | 158 |
GO:0045121 | membrane raft | 4.27e-01 | 1.00e+00 | 0.856 | 1 | 3 | 161 |
GO:0000398 | mRNA splicing, via spliceosome | 4.34e-01 | 1.00e+00 | 0.821 | 1 | 2 | 165 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 4.40e-01 | 1.00e+00 | 0.795 | 1 | 4 | 168 |
GO:0007420 | brain development | 4.48e-01 | 1.00e+00 | 0.761 | 1 | 3 | 172 |
GO:0016607 | nuclear speck | 4.54e-01 | 1.00e+00 | 0.736 | 1 | 2 | 175 |
GO:0004672 | protein kinase activity | 4.59e-01 | 1.00e+00 | 0.711 | 1 | 4 | 178 |
GO:0006351 | transcription, DNA-templated | 4.64e-01 | 1.00e+00 | 0.142 | 6 | 17 | 1585 |
GO:0007596 | blood coagulation | 4.76e-01 | 1.00e+00 | 0.329 | 2 | 5 | 464 |
GO:0006468 | protein phosphorylation | 4.79e-01 | 1.00e+00 | 0.320 | 2 | 6 | 467 |
GO:0042802 | identical protein binding | 5.06e-01 | 1.00e+00 | 0.248 | 2 | 4 | 491 |
GO:0030168 | platelet activation | 5.08e-01 | 1.00e+00 | 0.508 | 1 | 4 | 205 |
GO:0001701 | in utero embryonic development | 5.16e-01 | 1.00e+00 | 0.473 | 1 | 2 | 210 |
GO:0004871 | signal transducer activity | 5.26e-01 | 1.00e+00 | 0.432 | 1 | 1 | 216 |
GO:0005765 | lysosomal membrane | 5.30e-01 | 1.00e+00 | 0.419 | 1 | 2 | 218 |
GO:0016874 | ligase activity | 5.39e-01 | 1.00e+00 | 0.380 | 1 | 2 | 224 |
GO:0030425 | dendrite | 5.64e-01 | 1.00e+00 | 0.280 | 1 | 3 | 240 |
GO:0005874 | microtubule | 5.91e-01 | 1.00e+00 | 0.176 | 1 | 3 | 258 |
GO:0005102 | receptor binding | 6.05e-01 | 1.00e+00 | 0.121 | 1 | 2 | 268 |
GO:0000166 | nucleotide binding | 6.10e-01 | 1.00e+00 | 0.100 | 1 | 2 | 272 |
GO:0003779 | actin binding | 6.15e-01 | 1.00e+00 | 0.084 | 1 | 3 | 275 |
GO:0005783 | endoplasmic reticulum | 6.24e-01 | 1.00e+00 | -0.066 | 2 | 6 | 610 |
GO:0042493 | response to drug | 6.32e-01 | 1.00e+00 | 0.017 | 1 | 2 | 288 |
GO:0006954 | inflammatory response | 6.33e-01 | 1.00e+00 | 0.012 | 1 | 1 | 289 |
GO:0007165 | signal transduction | 6.41e-01 | 1.00e+00 | -0.120 | 3 | 7 | 950 |
GO:0016567 | protein ubiquitination | 6.46e-01 | 1.00e+00 | -0.037 | 1 | 3 | 299 |
GO:0005743 | mitochondrial inner membrane | 6.47e-01 | 1.00e+00 | -0.042 | 1 | 1 | 300 |
GO:0006955 | immune response | 6.53e-01 | 1.00e+00 | -0.066 | 1 | 2 | 305 |
GO:0005886 | plasma membrane | 6.55e-01 | 1.00e+00 | -0.112 | 9 | 24 | 2834 |
GO:0030154 | cell differentiation | 6.76e-01 | 1.00e+00 | -0.157 | 1 | 3 | 325 |
GO:0008283 | cell proliferation | 6.83e-01 | 1.00e+00 | -0.184 | 1 | 4 | 331 |
GO:0005524 | ATP binding | 6.94e-01 | 1.00e+00 | -0.216 | 4 | 19 | 1354 |
GO:0007275 | multicellular organismal development | 6.97e-01 | 1.00e+00 | -0.239 | 1 | 2 | 344 |
GO:0005576 | extracellular region | 7.07e-01 | 1.00e+00 | -0.263 | 3 | 4 | 1049 |
GO:0015031 | protein transport | 7.11e-01 | 1.00e+00 | -0.293 | 1 | 4 | 357 |
GO:0008285 | negative regulation of cell proliferation | 7.21e-01 | 1.00e+00 | -0.333 | 1 | 3 | 367 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 7.34e-01 | 1.00e+00 | -0.360 | 2 | 9 | 748 |
GO:0006355 | regulation of transcription, DNA-templated | 7.40e-01 | 1.00e+00 | -0.336 | 3 | 10 | 1104 |
GO:0046872 | metal ion binding | 7.52e-01 | 1.00e+00 | -0.330 | 4 | 14 | 1465 |
GO:0045892 | negative regulation of transcription, DNA-templated | 7.72e-01 | 1.00e+00 | -0.541 | 1 | 2 | 424 |
GO:0006366 | transcription from RNA polymerase II promoter | 7.72e-01 | 1.00e+00 | -0.544 | 1 | 3 | 425 |
GO:0008150 | biological_process | 7.98e-01 | 1.00e+00 | -0.655 | 1 | 3 | 459 |
GO:0055114 | oxidation-reduction process | 8.13e-01 | 1.00e+00 | -0.723 | 1 | 2 | 481 |
GO:0005509 | calcium ion binding | 8.73e-01 | 1.00e+00 | -1.015 | 1 | 4 | 589 |
GO:0042803 | protein homodimerization activity | 8.85e-01 | 1.00e+00 | -1.082 | 1 | 4 | 617 |
GO:0008270 | zinc ion binding | 8.89e-01 | 1.00e+00 | -0.872 | 2 | 7 | 1067 |
GO:0003677 | DNA binding | 9.52e-01 | 1.00e+00 | -1.213 | 2 | 14 | 1351 |
GO:0005887 | integral component of plasma membrane | 9.67e-01 | 1.00e+00 | -1.721 | 1 | 2 | 961 |
GO:0005615 | extracellular space | 9.72e-01 | 1.00e+00 | -1.793 | 1 | 3 | 1010 |
GO:0016021 | integral component of membrane | 1.00e+00 | 1.00e+00 | -3.091 | 1 | 4 | 2483 |